Global biopharmaceutical company Sanofi (NASDAQ: SNY) encountered setbacks while developing its COVID-19 vaccine, and only this year reported results from late-stage clinical trials. The company ...

Sanofi (NASDAQ: SNY) believes it has a potential blockbuster in its innovative new cancer-fighting drug. If the company is right, investing now could pay off handsomely in the future, for those ...

French pharmaceutical giant Sanofi (NASDAQ: SNY) has long been a leader in the market for insulin. However, the company recently made two notable moves that could affect its trajectory in the ...

Sanofi (Nasdaq: SNY), an innovative global healthcare company, visits the Nasdaq MarketSite in Times Square to celebrate the more than one million patients around the world actively on treatment ...

Shares of Sanofi (NASDAQ: SNY) were up 10.20% the week ended March 24, while Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) finished with a gain of 9.68%, following promising news about the ...

Last month, Sanofi (NASDAQ: SNY) and Regeneron's (NASDAQ: REGN) immunology mega-blockbuster, known as Dupixent, received some good news. The European Medicines Agency's Committee for Medicinal ...

Sanofi ’s SNY stock has declined 10.2% in the past three months. However, a lot of this price decline was due to the downtrend of the overall drug and biotech sector, which performed poorly in ...

French pharmaceutical company Sanofi (NASDAQ: SNY) is seeing a jump in its share price following major product news on Feb. 23. The company shared that the Food and Drug Administration (FDA) had ...

Sanofi (SNY) closed at $51.54 in the latest trading session, marking a +1.3% move from the prior day. This move outpaced the S&P 500's daily gain of 0.62%. Elsewhere, the Dow gained 0.5%, while ...

Sanofi (SNY) closed at $55.47 in the latest trading session, marking a -0.45% move from the prior day. This change was narrower than the S&P 500's daily loss of 0.6%. Meanwhile, the Dow lost 0.33% ...

The French-based pharmaceutical company Sanofi (NASDAQ: SNY) has been flying under the radar over the past few years as companies like AbbVie, Bristol Myers Squibb, and Merck have dominated the ...

In the latest trading session, Sanofi (SNY) closed at $53.67, marking a +0.36% move from the previous day. This change lagged the S&P 500's 1.15% gain on the day. Elsewhere, the Dow gained 0.63% ...